High serum levels of TNF-α after its administration for isolation perfusion of the limb

This publication has 22 references indexed in Scilit:

• Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites
  European Journal of Cancer and Clinical Oncology, 1991
• Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin
  Cellular Immunology, 1991
• Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity
  Cancer Immunology, Immunotherapy, 1991
• Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial
  European Journal of Cancer and Clinical Oncology, 1991
• Effect of tumor necrosis factor on human tumor cell lines sensitive and resistant to cytotoxic drugs, and its interaction with chemotherapeutic agents
  Anti-Cancer Drugs, 1990
• Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.
  BMJ, 1989
• Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor
  Journal of Clinical Immunology, 1989
• Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
  The Journal of cell biology, 1988
• Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
  Journal of Clinical Investigation, 1988
• ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
  The Lancet, 1987